Dare Bioscience, Inc. Payments of Stock Issuance Costs
Dare Bioscience, Inc. (DARE) reported Payments of Stock Issuance Costs of $175.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-30
- Dare Bioscience, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was -$32.00K.
- Dare Bioscience, Inc. payments of stock issuance costs for the quarter ending 2021-09-30 was $0.00.
- Dare Bioscience, Inc. payments of stock issuance costs for the quarter ending 2019-03-31 was $237.40K.
- Dare Bioscience, Inc. payments of stock issuance costs for the quarter ending 2018-09-30 was $0.00.
- Dare Bioscience, Inc. payments of stock issuance costs for fiscal 2021 was $175.00K, a 25.85% decline from fiscal 2020.
- Dare Bioscience, Inc. payments of stock issuance costs for fiscal 2020 was $236.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 100 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$32.00K derived: sum of 2 quarters · filed 2023-03-30 | $175.00K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $207.00K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $207.00K 10-Q · filed 2022-08-09 | ||||
| 2020-12-31 | $236.00K 10-K · filed 2022-03-31 | ||||
| 2019-03-31 | $237.40K 10-Q · filed 2019-05-14 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $237.40K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $237.40K 10-Q · filed 2019-08-14 | ||||
| 2014-03-31 | $1.06M 10-Q · filed 2014-05-27 | $1.50M 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |